Skip to main content
Caplight Logo









AOBiome Therapeutics Inc.

AOBiome Therapeutics Inc.

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.aobiome.com/

Last Round

Series C

Jan 5, 2017

Total Funding Raised

$30M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AOBiome Therapeutics Inc. is a biotechnology company that develops a novel class of therapeutics for inflammatory conditions, central nervous system disorders, and other systemic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Fashion & Beauty

Business Model

B2B2C

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

live biotherapeuticmicrobiome therapeuticsskin microbiomeinflammatory skin diseaseatopic dermatitiseczema treatmentB244Ammonia Oxidizing BacteriaAOBacne vulgarisrosaceaLBPclinical-stage biotechbacterial therapytopical formulationprurituspharmaceutical licensingcosmetic skin mist

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AOBiome Therapeutics Inc. Comparables

Compare AOBiome Therapeutics Inc. with similar companies based on industry and business-model similarity.

AOBiome Therapeutics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MatriSys Bioscience
84%
DermBiont
84%
Azitra, Inc.
82%

AOBiome Therapeutics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJan 5, 2017
VC RoundSep 1, 2015

Key People

Founding team and executive leadership

Jim Hoffman

Chief Operating Officer & Board Member

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors grew 49% MoM.

  • Nov 12, 2025

    Monthly visitors grew 62% MoM, reaching 2.4K.

AOBiome Therapeutics Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AOBiome Therapeutics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AOBiome Therapeutics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range18
Year Founded2012
Last FundingJan 5, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?